Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Evaluate whether travel rewards or cash back cards are better for you. Find the card that maximizes your benefits.
26,293 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
A major reshuffle around Microsoft and OpenAI could shift AI momentum in tech clouds. This article explains why amazo...
A year ago, the idea that AI could tame inflation sounded compelling. Today, the same tech may be adding price pressu...
Silicon Valley’s long-running belief that technology could change the world is fading as market realities and politic...
When a prenatal diagnosis changes the path of a family, smart financial planning becomes essential. This article offe...
What a difference a year makes. Last year, Wall Street questioned this AI stock’s valuation. Today, analysts anticipa...
Tesla is steering its $25 billion capex plan beyond cars and into AI and robotics. This shift could transform margins...
Alpha Omega Semiconductor stock has doubled this year, but is the rally justified? This guide breaks down the busines...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
Meta is pressing ahead with a sweeping AI infrastructure plan even after laying 8,000 employees. CEO Mark Zuckerberg ...
A legendary production designer reshaped 1969 Los Angeles for a Tarantino film, and her approach offers practical mon...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...